FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Kwan Rudolf
2. Issuer Name and Ticker or Trading Symbol

Athenex, Inc. [ ATNX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP, Chief Medical Officer
(Last)          (First)          (Middle)

C/O ATHENEX, INC.,, 1001 MAIN STREET, SUITE 600
3. Date of Earliest Transaction (MM/DD/YYYY)

12/30/2022
(Street)

BUFFALO, NY 14203
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/30/2022  A  33220 A$0.1475 (1)538579 (2)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) $4.55           1/2/2016 1/2/2023 Common Stock 96000  96000 D  
Stock Option (Right to Buy) $4.55           5/13/2018 5/13/2023 Common Stock 48000  48000 D  
Stock Option (Right to Buy) $4.55           2/12/2018 2/12/2024 Common Stock 120000  120000 D  
Stock Option (Right to Buy) $4.55           6/12/2017 6/12/2024 Common Stock 48000  48000 D  
Stock Option (Right to Buy) $5.50           12/16/2018 12/16/2024 Common Stock 200000  200000 D  
Stock Option (Right to Buy) $7.50           5/22/2019 5/22/2025 Common Stock 120000  120000 D  
Stock Option (Right to Buy) $11.00           6/13/2020 6/13/2027 Common Stock 140000  140000 D  
Stock Option (Right to Buy) $17.30           3/27/2022 3/27/2028 Common Stock 120000  120000 D  
Stock Option (Right to Buy) $13.17            (3)2/28/2029 Common Stock 120000  120000 D  
Stock Option (Right to Buy) $12.45            (4)6/5/2030 Common Stock 140000  140000 D  
Stock Option (Right to Buy) $3.80            (5)8/3/2031 Common Stock 70000  70000 D  
Restricted Stock Units  (6)           (7) (7)Common Stock 52500  52500 D  
Stock Option (Right to Buy) $0.6655            (8)7/20/2032 Common Stock 75000  75000 D  

Explanation of Responses:
(1) Shares purchased from the Issuer under a Salary Deduction and Stock Purchase Agreement at the Nasdaq Official Closing Price on the date of purchase.
(2) Includes 3 shares acquired under the Athenex, Inc. 2017 Employee Stock Purchase Plan.
(3) This option vests in four equal annual installments beginning on February 28, 2020.
(4) This option vests in four equal annual installments beginning on June 5, 2021.
(5) The option vests in four equal annual installments beginning on August 3, 2022.
(6) Each restricted stock unit represents a contingent right to receive one share of stock.
(7) The restricted stock units vest in four equal annual installments beginning on August 3, 2022.
(8) This option vests in four equal annual installments beginning on July 20, 2023.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Kwan Rudolf
C/O ATHENEX, INC.,
1001 MAIN STREET, SUITE 600
BUFFALO, NY 14203


EVP, Chief Medical Officer

Signatures
/s/ Steven Adams, Attorney-in-Fact1/3/2023
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Athenex (NASDAQ:ATNX)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Athenex Charts.
Athenex (NASDAQ:ATNX)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Athenex Charts.